Financials
Financial year 2025
NZASENGA AKAYESU MED from Arlon, company number BE1002838854, closed financial year 2025 with a result of € 38,545 after tax. For that financial year NZASENGA AKAYESU MED recorded a gross margin of € 97,248 and equity of € 114,977. Compared with financial year 2024, the result moved from € 75,432 to € 38,545. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.
€ 114,977
▲ 50% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 38,545
▼ 49% vs 2024
Profit after tax over the fiscal year.
€ 78,283
▼ 15% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 113,977.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 70,036
▼ 25% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 219,522
▲ 132% vs 2024
€ 30,240 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 1,801
▲ 190% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,148
▼ 83% vs 2024
Taxes, VAT and social contributions still to pay.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 121,847 | € 97,248 | ▼ 20% |
| Profit after taxes | € 75,432 | € 38,545 | ▼ 49% |
| Equity | € 76,432 | € 114,977 | ▲ 50% |
| Total debts | € 119,510 | € 227,170 | ▲ 90% |
| Cash | € 92,257 | € 78,283 | ▼ 15% |
| Land & buildings | - | € 148,521 | |
| Retained profit | € 75,432 | € 113,977 | ▲ 51% |
| Bank debt | € 94,609 | € 219,522 | ▲ 132% |
| Balance sheet total | € 195,942 | € 342,147 | ▲ 75% |
Key figures of NZASENGA AKAYESU MED, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about NZASENGA AKAYESU MED the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to NZASENGA AKAYESU MED?
What happened at NZASENGA AKAYESU MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 38,545 (▼ 49% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Arlon. KBO
In short
From € 75,432 profit in 2024 to € 38,545 profit in 2025.
Paid € 31,102 in corporate taxes since 2024.
Best year ever: 2024, with € 75,432 profit.
Management
Behind NZASENGA AKAYESU MED is SYLVIE NZASENGA.
Directors
According to the 2025 annual accounts
SYLVIE NZASENGA
Director
Establishments
Establishment units
Physical locations of this company
Rue François-Boudart 13
6700 Arlon
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- NZASENGA Sylvie(oprichter, enige aandeelhouder) 100%
Details
- Company number
- 1002.838.854
- VAT number
- BE 1002.838.854
- Registered office
- Rue François-Boudart 13, 6700 Arlon
- Names & denominations
- NZASENGA AKAYESU MED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 November 2023
- Peppol
- Active · Active since 6 Jan 2026
- Contact
- [email protected] +32492429085